Literature DB >> 29391907

Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?

Hyung-Jun Im1,2, Tyler Bradshaw1, Meiyappan Solaiyappan3, Steve Y Cho1,3,4.   

Abstract

Numerous methods to segment tumors using 18F-fluorodeoxyglucose positron emission tomography (FDG PET) have been introduced. Metabolic tumor volume (MTV) refers to the metabolically active volume of the tumor segmented using FDG PET, and has been shown to be useful in predicting patient outcome and in assessing treatment response. Also, tumor segmentation using FDG PET has useful applications in radiotherapy treatment planning. Despite extensive research on MTV showing promising results, MTV is not used in standard clinical practice yet, mainly because there is no consensus on the optimal method to segment tumors in FDG PET images. In this review, we discuss currently available methods to measure MTV using FDG PET, and assess the advantages and disadvantages of the methods.

Entities:  

Keywords:  18F-fluorodeoxyglucose; Metabolic tumor volume; Positron emission tomography; Segmentation; Tumor

Year:  2017        PMID： 29391907      PMCID： PMC5777960          DOI： 10.1007/s13139-017-0493-6

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


  63 in total

1.  FDG-PET in radiotherapy treatment planning: Pandora's box?

Authors:  Arnold C Paulino; Peter A S Johnstone
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-05-01       Impact factor: 7.038

2.  Snakes, shapes, and gradient vector flow.

Authors:  C Xu; J L Prince
Journal:  IEEE Trans Image Process       Date:  1998       Impact factor: 10.856

3.  Value of metabolic tumor volume on repeated 18F-FDG PET/CT for early prediction of survival in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.

Authors:  Wei Huang; Min Fan; Bo Liu; Zheng Fu; Tao Zhou; Zicheng Zhang; Heyi Gong; Baosheng Li
Journal:  J Nucl Med       Date:  2014-09-11       Impact factor: 10.057

4.  Impact of the definition of peak standardized uptake value on quantification of treatment response.

Authors:  Matt Vanderhoek; Scott B Perlman; Robert Jeraj
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

5.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

6.  Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.

Authors:  Do-Hoon Kim; Seung Hyun Son; Choon-Young Kim; Chae Moon Hong; Jong-Ryool Oh; Bong-Il Song; Hae Won Kim; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

7.  18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?

Authors:  Kenneth J Biehl; Feng-Ming Kong; Farrokh Dehdashti; Jian-Yue Jin; Sasa Mutic; Issam El Naqa; Barry A Siegel; Jeffrey D Bradley
Journal:  J Nucl Med       Date:  2006-11       Impact factor: 10.057

8.  Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.

Authors:  Yoshiaki Zaizen; Koichi Azuma; Seiji Kurata; Eiji Sadashima; Satoshi Hattori; Tetsuro Sasada; Yohei Imamura; Hayato Kaida; Akihiko Kawahara; Takashi Kinoshita; Masatoshi Ishibashi; Tomoaki Hoshino
Journal:  Eur J Radiol       Date:  2012-08-09       Impact factor: 3.528

9.  Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.

Authors:  Hyung-Jun Im; Kyoungjune Pak; Gi Jeong Cheon; Keon Wook Kang; Seong-Jang Kim; In-Joo Kim; June-Key Chung; E Edmund Kim; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-06       Impact factor: 9.236

10.  Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.

Authors:  Ie Ryung Yoo; Soo Kyo Chung; Hye Lim Park; Woo Hee Choi; Young Kyoon Kim; Kyo Young Lee; Young-Pil Wang
Journal:  Biomed Mater Eng       Date:  2014       Impact factor: 1.300
View more
  45 in total

1.  Multi-level otsu method to define metabolic tumor volume in positron emission tomography.

Authors:  Hyung-Jun Im; Meiyappan Solaiyappan; Inki Lee; Tyler Bradshaw; Najat C Daw; Fariba Navid; Barry L Shulkin; Steve Y Cho
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20

2.  The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study.

Authors:  Vittoria Rufini; Angela Collarino; Maria Lucia Calcagni; Guido Maria Meduri; Valentina Fuoco; Tina Pasciuto; Antonia Carla Testa; Gabriella Ferrandina; Maria Antonietta Gambacorta; Maura Campitelli; Benedetta Gui; Gianfranco Zannoni; Riccardo Manfredi; Giovanni Scambia; Alessandro Giordano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-14       Impact factor: 9.236

3.  Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology.

Authors:  Austin R Pantel; Varsha Viswanath; Mark Muzi; Robert K Doot; David A Mankoff
Journal:  J Nucl Med       Date:  2022-03       Impact factor: 10.057

4.  The role of quantitative tumor burden based on [68 Ga]Ga-DOTA-NOC PET/CT in well-differentiated neuroendocrine tumors: beyond prognosis.

Authors:  Luohai Chen; Nuerailaguli Jumai; Qiao He; Man Liu; Yuan Lin; Yanji Luo; Yu Wang; Min-Hu Chen; Zhirong Zeng; Xiangsong Zhang; Ning Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-10-01       Impact factor: 10.057

5.  Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.

Authors:  Gerben J C Zwezerijnen; Jakoba J Eertink; Maria C Ferrández; Sanne E Wiegers; Coreline N Burggraaff; Pieternella J Lugtenburg; Martijn W Heymans; Henrica C W de Vet; Josée M Zijlstra; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-27       Impact factor: 10.057

6.  EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).

Authors:  Roberto C Delgado Bolton; Nicolas Aide; Patrick M Colletti; Annamaria Ferrero; Diana Paez; Andrea Skanjeti; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-03       Impact factor: 9.236

7.  Prognostic value of metabolic parameters on 18F-fluorodeoxyglucose positron tomography/computed tomography in classical rectal adenocarcinoma.

Authors:  Byung Wook Choi; Sungmin Kang; Sung Uk Bae; Woon Kyung Jeong; Seong Kyu Baek; Bong-Il Song; Kyoung Sook Won; Hae Won Kim
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

8.  Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer.

Authors:  Tae Hoon Lee; Hyun Gee Ryoo; Reeree Lee; Jin Chul Paeng; Hyunsoo Chung; Hak Jae Kim
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

9.  Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031.

Authors:  Sarah A Milgrom; Jihyun Kim; Alin Chirindel; Jongho Kim; Qinglin Pei; Lu Chen; Allen Buxton; Sandy Kessel; Jeffrey Leal; Kathleen M McCarten; Bradford S Hoppe; Suzanne L Wolden; Cindy L Schwartz; Debra L Friedman; Kara M Kelly; Steve Y Cho
Journal:  Pediatr Blood Cancer       Date:  2021-07-10       Impact factor: 3.838

10.  Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma.

Authors:  Gerben J C Zwezerijnen; Jakoba J Eertink; Coreline N Burggraaff; Sanne E Wiegers; Ekhlas A I N Shaban; Simone Pieplenbosch; Daniela E Oprea-Lager; Pieternella J Lugtenburg; Otto S Hoekstra; Henrica C W de Vet; Josee M Zijlstra; Ronald Boellaard
Journal:  J Nucl Med       Date:  2021-03-05       Impact factor: 11.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.